The vaccinated mice showed significant inhibition of tumor growth (Figure 4C), which was associated with strong CD4+ and CD8+ T cell responses specific to the tumor antigens targeted by the vaccine (Figure 4D and Figure S2). This evidence concerns the gene CD8A and neoplasm.